Evidence map›Paper›PMID 42342238›Full record

ArticleAnalytical chemistry2026

Assessing Surface Binding Events on Golgi Microsomes Isolated from Cancer Cells by Capillary Electrophoresis.

Clara Davoine, Gaël Cobraiville, Lionel Pochet, Marianne Fillet

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Clara DavoineLaboratory for the Analysis of Medicines (LAM), Department of Pharmacy, CIRM, University of Liege, Avenue Hippocrate 15, B36 Tour 4 + 3, Liège 4000, Belgium.ORCID 0000-0003-1110-8319
Gaël CobraivilleLaboratory for the Analysis of Medicines (LAM), Department of Pharmacy, CIRM, University of Liege, Avenue Hippocrate 15, B36 Tour 4 + 3, Liège 4000, Belgium.
Lionel PochetNamur Medicine & Drug Innovation Center (NAMEDIC - NARILIS), University of Namur, Rue de Bruxelles 61, Namur 5000, Belgium.ORCID 0000-0002-2560-9555
Marianne FilletLaboratory for the Analysis of Medicines (LAM), Department of Pharmacy, CIRM, University of Liege, Avenue Hippocrate 15, B36 Tour 4 + 3, Liège 4000, Belgium.ORCID 0000-0002-1453-6282

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracellular membrane proteins represent a vast and pharmacologically essential class of therapeutic targets, yet their characterization within native pathological environments remains experimentally challenging. Here, we report what is, to the best of our knowledge, the first direct affinity measurements performed at the surface of Golgi microsomes isolated from cancer cells. By integrating affinity capillary electrophoresis (ACE) with a refined mathematical framework, we overcome long-standing obstacles associated with membrane protein analysis, including the need for target modification, intrinsic enzymatic activity, labeled probe, or large protein excess. The microfluidic format further minimizes sample consumption while enabling both direct and indirect detection modalities, thereby expanding applicability to impure compounds and ligands lacking charge or UV absorbance. Applying this strategy to UGCG, a Golgi-resident membrane protein of oncological relevance, we demonstrate quantitative ligand-binding measurements on fairly monodisperse vesicular fractions (∼150 nm) that preserve native intracellular architecture. Collectively, this work establishes a robust, broadly applicable platform for target engagement studies in complex biological systems and highlights the potential of ACE to accelerate drug discovery efforts involving intracellular or extracellular membrane-bound targets.

Indexed as

Golgi ApparatusMicrosomesCell Line, TumorElectrophoresis, CapillaryHumansSurface Properties

Identifiers

PMID42342238
PMCPMC13347695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.